123 related articles for article (PubMed ID: 7875484)
1. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy.
Basile AS; Saito K; al-Mardini H; Record CO; Hughes RD; Harrison P; Williams R; Li Y; Heyes MP
Gastroenterology; 1995 Mar; 108(3):818-23. PubMed ID: 7875484
[TBL] [Abstract][Full Text] [Related]
2. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure.
Basile AS; Saito K; Li Y; Heyes MP
J Neurochem; 1995 Jun; 64(6):2607-14. PubMed ID: 7760040
[TBL] [Abstract][Full Text] [Related]
3. Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge.
Bergqvist PB; Heyes MP; Bugge M; Bengtsson F
J Neurochem; 1995 Nov; 65(5):2235-40. PubMed ID: 7595512
[TBL] [Abstract][Full Text] [Related]
4. Is quinolinic acid involved in the pathogenesis of hepatic encephalopathy?
Bergqvist PB; Heyes MP; Bengtsson F
Adv Exp Med Biol; 1996; 398():397-405. PubMed ID: 8906295
[No Abstract] [Full Text] [Related]
5. Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis.
Morrison PF; Morishige GM; Beagles KE; Heyes MP
J Neurochem; 1999 May; 72(5):2135-44. PubMed ID: 10217295
[TBL] [Abstract][Full Text] [Related]
6. Brain extracellular quinolinic acid in chronic experimental hepatic encephalopathy as assessed by in vivo microdialysis: acute effects of L-tryptophan.
Bergqvist PB; Heyes MP; Apelqvist G; Butterworth RF; Bengtsson F
Neuropsychopharmacology; 1996 Oct; 15(4):382-9. PubMed ID: 8887992
[TBL] [Abstract][Full Text] [Related]
7. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure.
Moroni F; Lombardi G; Carlà V; Lal S; Etienne P; Nair NP
J Neurochem; 1986 Dec; 47(6):1667-71. PubMed ID: 2430055
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine pathway metabolism in the galactosamine model of hepatic injury.
Saito K; Seishima M; Noma A; Nagamura Y; Quearry BJ; Markey SP; Heyes MP
Adv Exp Med Biol; 1996; 398():421-4. PubMed ID: 8906299
[No Abstract] [Full Text] [Related]
9. Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis.
Lahdou I; Sadeghi M; Oweira H; Fusch G; Daniel V; Mehrabi A; Jung G; Elhadedy H; Schmidt J; Sandra-Petrescu F; Iancu M; Opelz G; Terness P; Schefold JC
Hum Immunol; 2013 Jan; 74(1):60-6. PubMed ID: 23046794
[TBL] [Abstract][Full Text] [Related]
10. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.
Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C
J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500
[TBL] [Abstract][Full Text] [Related]
11. Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues.
Heyes MP; Morrison PF
J Neurochem; 1997 Jan; 68(1):280-8. PubMed ID: 8978736
[TBL] [Abstract][Full Text] [Related]
12. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.
Heyes MP; Saito K; Lackner A; Wiley CA; Achim CL; Markey SP
FASEB J; 1998 Jul; 12(10):881-96. PubMed ID: 9657528
[TBL] [Abstract][Full Text] [Related]
13. Effects of 540C91 [(E)-3-[2-(4'-pyridyl)-vinyl]-1H-indole], an inhibitor of hepatic tryptophan dioxygenase, on brain quinolinic acid in mice.
Reinhard JF; Flanagan EM; Madge DJ; Iyer R; Salter M
Biochem Pharmacol; 1996 Jan; 51(2):159-63. PubMed ID: 8615884
[TBL] [Abstract][Full Text] [Related]
14. Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy.
Bassett ML; Mullen KD; Scholz B; Fenstermacher JD; Jones EA
Gastroenterology; 1990 Mar; 98(3):747-57. PubMed ID: 2298374
[TBL] [Abstract][Full Text] [Related]
15. Cerebral metabolic and histological effects of thioacetamide-induced liver failure.
Peeling J; Shoemaker L; Gauthier T; Benarroch A; Sutherland GR; Minuk GY
Am J Physiol; 1993 Sep; 265(3 Pt 1):G572-8. PubMed ID: 8214078
[TBL] [Abstract][Full Text] [Related]
16. Brain indoles in human hepatic encephalopathy.
al Mardini H; Harrison EJ; Ince PG; Bartlett K; Record CO
Hepatology; 1993 Jun; 17(6):1033-40. PubMed ID: 7685732
[TBL] [Abstract][Full Text] [Related]
17. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
Levy LJ; Losowsky MS
Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
[TBL] [Abstract][Full Text] [Related]
18. Neuronal and glial marker proteins in encephalopathy associated with acute liver failure and acute hyperammonemia in the rabbit.
Groeneweg M; de Knegt RJ; Hamberger A; Ding M; Wang S; Schalm SW; Haglid KG
Metab Brain Dis; 1993 Jun; 8(2):95-106. PubMed ID: 8355642
[TBL] [Abstract][Full Text] [Related]
19. Activated human microglia produce the excitotoxin quinolinic acid.
Espey MG; Chernyshev ON; Reinhard JF; Namboodiri MA; Colton CA
Neuroreport; 1997 Jan; 8(2):431-4. PubMed ID: 9080423
[TBL] [Abstract][Full Text] [Related]
20. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
